{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:45:21Z","timestamp":1788371121111,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K06887"],"award-info":[{"award-number":["JP22K06887"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008665","name":"Osaka Medical Research Foundation for Intractable Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neulet.2025.138354","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:52:44Z","timestamp":1754927564000},"page":"138354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["DOPAnization of \u03b1-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra"],"prefix":"10.1016","volume":"865","author":[{"given":"Keisuke","family":"Togawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Hirotsune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2025.138354_b0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2025.138354_b0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson's disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2025.138354_b0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2025.138354_b0020","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138354_b0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138354_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","article-title":"Alpha-Synuclein gene duplication is present in sporadic Parkinson disease","volume":"70","author":"Ahn","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2025.138354_b0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/acschemneuro.6b00430","article-title":"Role of sporadic Parkinson disease associated mutations A18T and A29S in enhanced alpha-synuclein fibrillation and cytotoxicity","volume":"9","author":"Kumar","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neulet.2025.138354_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arr.2014.04.002","article-title":"Genetic variants and animal models in SNCA and Parkinson disease","volume":"15","author":"Deng","year":"2014","journal-title":"Age. Res. Rev."},{"key":"10.1016\/j.neulet.2025.138354_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114204","article-title":"Targeting alpha-synuclein post-translational modifications in Parkinson's disease","volume":"439","author":"Canever","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2025.138354_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1197853","article-title":"Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?","volume":"16","author":"Brembati","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2025.138354_b0055","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138354_b0060","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from alpha-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2025.138354_b0065","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":"alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2025.138354_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167714","article-title":"Functional and pathological effects of alpha-synuclein on synaptic SNARE complexes","volume":"435","author":"Gao","year":"2023","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neulet.2025.138354_b0075","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1038\/s41467-022-34555-4","article-title":"DOPAnization of tyrosine in alpha-synuclein by tyrosine hydroxylase leads to the formation of oligomers","volume":"13","author":"Jin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2025.138354_b0080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","article-title":"Alpha-synuclein-based animal models of parkinson's disease: challenges and opportunities in a new era","volume":"39","author":"Visanji","year":"2016","journal-title":"Trends Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.neulet.2025.138354_b0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.13627","article-title":"How can rAAV-alpha-synuclein and the fibril alpha-synuclein models advance our understanding of Parkinson's disease?","volume":"139","author":"Volpicelli-Daley","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2025.138354_b0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23747","article-title":"Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport","volume":"72","author":"Freundt","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2025.138354_b0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138354_b0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/jnc.14139","article-title":"'Prion-like' propagation of the synucleinopathy of M83 transgenic mice depends on the mouse genotype and type of inoculum","volume":"143","author":"Sargent","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2025.138354_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.14802\/jmd.19046.e","article-title":"Modeling alpha-synuclein propagation with preformed fibril injections","volume":"13","author":"Chung","year":"2020","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.neulet.2025.138354_b0110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12974-019-1636-8","article-title":"Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice","volume":"16","author":"Earls","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2025.138354_b0115","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2025.138354_b0120","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological alpha-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2025.138354_b0125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/biom5020282","article-title":"Seeking a mechanism for the toxicity of oligomeric alpha-synuclein","volume":"5","author":"Roberts","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neulet.2025.138354_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.conb.2017.08.004","article-title":"Striatal synapses, circuits, and Parkinson's disease","volume":"48","author":"Zhai","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neulet.2025.138354_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neulet.2025.138354_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105966","article-title":"Monitoring alpha-synuclein aggregation","volume":"176","author":"Estaun-Panzano","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2025.138354_b0145","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.123.001111","article-title":"Post-translational modifications of alpha-Synuclein, their Therapeutic potential and Crosstalk in Health and Neurodegenerative Diseases","author":"Hassanzadeh","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2025.138354_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167859","article-title":"Effects of Mutations and Post-Translational modifications on alpha-Synuclein In Vitro Aggregation","volume":"434","author":"Pancoe","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neulet.2025.138354_b0155","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neulet.2025.138354_b0160","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","article-title":"Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice","volume":"7","author":"Karampetsou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2025.138354_b0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nsmb.3433","article-title":"Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson's disease","volume":"24","author":"Zhang","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neulet.2025.138354_b0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2017.06.034","article-title":"Enzymatic O-GlcNAcylation of alpha-synuclein reduces aggregation and increases SDS-resistant soluble oligomers","volume":"655","author":"Zhang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2025.138354_b0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41589-024-01551-2","article-title":"O-GlcNAc forces an alpha-synuclein amyloid strain with notably diminished seeding and pathology","volume":"20","author":"Balana","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neulet.2025.138354_b0180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neulet.2025.138354_b0185","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1073\/pnas.1903049116","article-title":"Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling","volume":"116","author":"Sun","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2025.138354_b0190","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2025.138354_b0195","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025002423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025002423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:00:09Z","timestamp":1762290009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394025002423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"alternative-id":["S0304394025002423"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138354","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DOPAnization of \u03b1-synuclein exacerbates dopaminergic neurodegeneration in the substantia nigra","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"138354"}}